Drug Type Antibody drug conjugate (ADC) |
Synonyms ASY 87, ASY87 |
Action inhibitors |
Mechanism HSP70 heat-shock proteins inhibitors(HSP70 heat-shock proteins inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Plasma Cell Neoplasms | Preclinical | United States | 04 Dec 2023 | |
| T-Cell Lymphoma | Preclinical | United States | 04 Dec 2023 | |
| Triple Negative Breast Cancer | Preclinical | United States | 04 Dec 2023 |






